Steven Steinberg

Belatacept and Long-Term Outcomes in Kidney Transplantation

Flavio Vincenti, Lionel Rostaing, J.M. Boria Grinyo et al. · New England Journal of Medicine · 2016 · 759 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long-Term Extension of the BENEFIT Study

Lionel Rostaing, Flavio Vincenti, J.M. Grinyó et al. · American Journal of Transplantation · 2013 · 189 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients

Lionel Rostaing, P. Massari, Valter Duro Garcı́a et al. · Clinical Journal of the American Society of Nephrology · 2010 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients

Stéphan Busque, Joseph R. Leventhal, Daniel C. Brennan et al. · American Journal of Transplantation · 2009 · 152 citations · Full text

Pharmacy, Nephrology, Immunopharmacology +16

Two Years Postconversion From a Prograf-Based Regimen to a Once-Daily Tacrolimus Extended-Release Formulation in Stable Kidney Transplant Recipients

Rita R. Alloway, Steven Steinberg, Kassem Khalil et al. · Transplantation · 2007 · 80 citations

Medicine, Nephrology, Pharmacotherapy +17